Log in | Register

AAIPharma Services Appoints Senior Director of Quality Services

For the latest pharmaceutical news and updates - Sign up now!
Loading...

AAIPharma Services Corp., a provider of pharmaceutical product development services, announced today that it has appointed Eduardo Uribe to senior director of quality services at the company's Charleston, SC parenteral manufacturing facility. Uribe will oversee the facility's quality control organization as the company expands its manufacturing facility footprint.

"We're excited to bring a talented director such as Eduardo to the team," said Brian Dillion, senior director of quality at AAIPharma.

"Eduardo's experience with developing, implementing and managing quality systems for biotechnology and pharmaceutical companies and his comprehensive understanding of GMP compliance make him a great asset for AAIPharma." With more than 20 years of experience in the biotech and pharmaceutical industry, Uribe brings a wealth of global knowledge and understanding of GMP, ISO and EU guidelines. His experience base includes virology, forensic toxicology, bacterial, viral and recombinant vaccines manufacturing and expertise in a variety of fill/finish operations.

Uribe has served in a variety of executive roles at SmithKline Beecham, Merck & Co., and SkyePharma. Most recently, he was a quality systems manager at EMD Millipore, in San Diego and Temecula, California. Prior to that, he was a senior director of quality operations for Irvine Pharmaceutical Services.

Uribe is a graduate of Kutztown University where he earned a Bachelor of Science degree.

  

 

Join the Discussion
Rate Article:  Average 0 out of 5
register or log in to comment on this article!

0 Comments

Add Comment

Text Only 2000 character limit

Page 1 of 1

Blogs

The Tale of Two Deviations

The Tale of Two Deviations

Apr 23 | The QA Pharm

It stands to reason that pharmaceutical companies in compliance trouble also have problems with their Deviation Management and Corrective and Preventive Action (CAPA) System(s).

Can the Combination of Creative Destruction and “Steve Jobs’ Traits” Lead to a “Pharma QbD Spring”?

Can the Combination of Creative Destruction and “Steve Jobs’ Traits” Lead to a “Pharma QbD Spring”?

Apr 16 | Girish Malhotra, PE, President, EPCOT International

The answer is an unequivocal yes but we need some outsiders who can conspire with the insiders who will be the flag bearers within the companies. Outsiders can be the counsels/co-conspirators to the insiders for the coup d'etat.

Multimedia

Lung Cancer Drug Treats Rare Lymphoma Tumors

Lung Cancer Drug Treats Rare Lymphoma Tumors

May 17 | Video

A new study found Xalkori effective in treating anaplastic lymphoma among children, an encouraging development for gene-targeted therapy.

Merck - 2012 Facility of the Year Award - Facility Integration

Merck - 2012 Facility of the Year Award - Facility Integration

May 14 | Video

Brian Morrissey, Senior Project Engineer, Merck Manufacturing Division, talks to Pharmaceutical Processing's Editor In Chief Mike Auerbach during INTERPHEX 2012 about the company's Vaccine Bulk Manufacturing Facility Program of Projects. The facility has won the Facility Integration award in the 2012 Facility of the Year Award competition sponsored by ISPE, INTERPHEX and Pharmaceutical Processing magazine.

Medicine from a Vending Machine?

Medicine from a Vending Machine?

May 3 | Video

A Chinese company is pushing for acceptance of traditional Chinese medicine with a machine that can dispense herbs.

Taking Precautions to Prevent Contagion

Taking Precautions to Prevent Contagion

Apr 29 | Video

With the recent outbreak of viruses such as SARS, bird flu and swine flu, officials and travelers are being extra careful about preventing the illnesses from being transmitted.

Top Stories and Headlines
EVERY DAY!

FREE Email Newsletter